Clinical Trial Update: Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating propranolol to reduce stress-mediated gene expression pathways in hematopoietic stem cell transplant recipients with multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-06-07